Found 0 matching trials
A Phase II Trial of Modified FOLFOX 6 and Cetuximab in First Line Treatment of Metastatic Colorectal Cancer PHASE2 This is a Phase II, open label, non-randomized study in patients with histo...
Show More Learn More & Join Trial
Intratumoral Microdosing of TAK-981 in Head and Neck Cancer EARLY_PHASE1 This is a multi-center, single arm, open-label, multi-agent, localized phar...
Show More Location
University of Michigan
Learn More & Join Trial
A Trial of SHR-A2102 With Adebrelimab With or Without Other Anti-tumor Therapies in Recurrent/MetastaticHead and Neck Squamous Cell Carcinoma Cancer PHASE1 The study is being conducted to evaluate the safety, tolerability and effic...
Show More Location
Chongqing University Cancer Hospital
Learn More & Join Trial
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Bank of Cyprus Oncology Centre
Learn More & Join Trial
Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck PHASE3 Prevention of critical weight loss. In patients with Squamous Cell Carcinom...
Show More Location
Landeskrankenhaus Feldkirch
Learn More & Join Trial
Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases NA The correlation between the values of angiogenesis-related growth factors i...
Show More Learn More & Join Trial
Allogenic Immunotherapy Based on Natural Killer (NK) Cell Adoptive Transfer in Metastatic Gastrointestinal Carcinoma Treated With Cetuximab PHASE1 Gastrointestinal (GI) cancers account for the most common cancers. Despite ...
Show More Location
University hospital of Besançon
Learn More & Join Trial
EMMA-1 (Erbitux for Multiple Myeloma) PHASE2 EMMA-1 is an open-label, non-randomized, two-stage phase II study. Patients...
Show More Location
University of Cologne, Department I of Internal Medicine
Learn More & Join Trial
A Study of LY2801653 in Advanced Cancer PHASE1 Part A- The purpose of this study is to determine a safe dose of LY2801653 ...
Show More Location
Arizona Cancer Center
Learn More & Join Trial
Combination Chemotherapy Plus Cetuximab in Treating Patients With Liver Metastases From Colorectal Cancer PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Mobile Infirmary Medical Center
Learn More & Join Trial